Recipharm’s Proprietary Molecule Erdosteine Has Been Positively Tested As Part Of COVID-19 Treatment
Leading Pharmaceutic… · 06:37 22 Oct 2020
Recipharm is pleased to announce that the results of the study with Erdosteine as an add-on treatment for COVID-19 patients are now available. The clinical study involved 20 patients affecte… Read More